Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2001European Heart JournalOpen Access

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme

View Full Paper
Ask AI
Bookmark
Share

Key result

A European survey of 5,556 coronary patients found high rates of modifiable risk factors, including 21% smoking, 31% obesity, and 50% raised blood pressure, alongside inadequate drug therapy use.

Population

8,181 men and women ≤70 years with established coronary heart disease from 15 European countries.

Design

Cross-sectional

Follow-up

median 1.4 years after hospital discharge

Discussion

Loading...

Member takes

Implication

Highlights gaps in secondary prevention among European coronary patients; leaves open whether contemporary strategies have improved adherence.

Study Design

Type

Cross-Sectional (n=5,556)

Multicenter

Yes

Structured PICO

P
Population
5,556 interviewed patients aged ≤70 years with established coronary heart disease across 15 European countries, assessed at a median of 1.4 years after hospital discharge.
O
Outcome
Adherence to the Joint European Societies' recommendations on coronary prevention (lifestyle, risk factor management, and use of prophylactic drug therapies)

This survey highlights a significant gap between secondary prevention guidelines and clinical practice in European coronary patients, demonstrating high rates of unhealthy lifestyles and inadequately controlled risk factors.

Limitations

  • Recording of risk factor history and risk factor measurement in hospital notes was incomplete, particularly for discharge documents.

Cite This Study

A 2001 study conducted a cross-sectional in established coronary heart disease (n=5,556). Lifestyle and risk factor management was evaluated on Prevalence of modifiable risk factors and use of prophylactic drug therapies. A European survey of 5,556 coronary patients found high rates of modifiable risk factors, including 21% smoking, 31% obesity, and 50% raised blood pressure, alongside inadequate drug therapy use.

synapsesocial.com/papers/6a51459dbd16ddce18b792dbhttps://doi.org/10.1053/euhj.2001.2610
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The burden of cardiovascular diseases mortality in Europe: Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe1997 · 788 citations
  2. 2Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction1996 · 281 citations
  3. 3Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients2000 · 8,695 citations
  4. 4The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels1996 · 7,498 citations